Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis

109Citations
Citations of this article
131Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The poor access of therapeutic drugs and genetic material into the central nervous system due to the presence of the blood-brain barrier often limits the development of effective noninvasive treatments and diagnoses of neurological disorders. Moreover, the delivery of genetic material into neuronal cells remains a challenge because of the intrinsic difficulty in transfecting this cell type. Nanotechnology has arisen as a promising tool to provide solutions for this problem. This review will cover the different approaches that have been developed to deliver drugs and genetic material efficiently to the central nervous system as well as the main nanomaterials used to image the central nervous system and diagnose its disorders.

Cite

CITATION STYLE

APA

Posadas, I., Monteagudo, S., & Ceña, V. (2016, April 1). Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis. Nanomedicine. Future Medicine Ltd. https://doi.org/10.2217/nnm.16.15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free